Physician attitudes regarding breakthrough varicella disease and a potential second dose of varicella vaccine

Matthew M Davis1, Mona Marin, Anne E Cowan

  • 1Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, MI, USA. mattdav@med.umich.edu

Pediatrics
|February 3, 2007
PubMed

Insights

Most physicians support the 1-dose varicella vaccine program, but many have seen breakthrough disease. A 2-dose recommendation may increase adoption, especially with a combination vaccine.

Area of Science:

  • Immunization practices
  • Pediatric infectious diseases
  • Public health policy

Background:

  • The 1-dose varicella vaccination program is widely recommended by physicians.
  • A significant percentage of physicians report observing breakthrough varicella disease.
  • Physician attitudes towards a 2-dose varicella vaccine recommendation are varied.

Purpose of the Study:

  • To assess pediatricians' and family physicians' attitudes regarding the current 1-dose varicella vaccination schedule.
  • To determine physicians' perceptions of the necessity for a 2-dose varicella vaccine recommendation to mitigate breakthrough disease.
  • To explore factors influencing physician willingness to adopt a 2-dose varicella vaccination strategy.

Main Methods:

  • A national mail survey was administered to 550 pediatricians and 550 family physicians in 2005.
  • Eligible participants were physicians providing primary outpatient care to children aged 6 years or younger.
  • A total of 727 surveys were returned, yielding a 69% response rate, with 610 physicians eligible for analysis.

Main Results:

  • 94% of surveyed physicians routinely recommend the 1-dose varicella vaccine.
  • 79% of respondents have encountered breakthrough varicella disease within the last 5 years.
  • Only 38% agreed a second dose is necessary, though 65% of pediatricians and 39% of family physicians would adopt a 2-dose recommendation if officially advised.

Conclusions:

  • Physicians generally support the existing 1-dose varicella vaccination policy.
  • Physician adoption of a 2-dose recommendation may increase with official guidance from the Advisory Committee on Immunization Practices.
  • The availability of a combination measles-mumps-rubella-varicella vaccine could further encourage the uptake of a 2-dose varicella schedule.
Abstract

Related Concept Videos

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations01:51

Vaccinations

Overview
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cross-reactivity00:42

Cross-reactivity

Overview